Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
2.160
-0.060 (-2.70%)
Nov 7, 2025, 4:00 PM EST - Market closed
Metagenomi Employees
Metagenomi had 202 employees as of December 31, 2024. The number of employees decreased by 34 or -14.41% compared to the previous year.
Employees
202
Change (1Y)
-34
Growth (1Y)
-14.41%
Revenue / Employee
$167,168
Profits / Employee
-$431,277
Market Cap
81.07M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 202 | -34 | -14.41% |
| Dec 31, 2023 | 236 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MGX News
- 17 days ago - Metagenomi taps Amazon's custom chips to develop gene-editing tools - Reuters
- 3 months ago - Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Metagenomi Appoints Laurence Reid, PhD to its Board of Directors - GlobeNewsWire
- 6 months ago - Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025 - GlobeNewsWire
- 6 months ago - Metagenomi Reports Business Updates and First Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - Metagenomi to Present at Upcoming Scientific Meetings - GlobeNewsWire
- 8 months ago - Metagenomi Reports Business Updates and Full Year 2024 Financial Results - GlobeNewsWire
- 8 months ago - Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems - GlobeNewsWire